Risk assessment of HBV-related HCC development using liver stiffness measurement

被引:0
|
作者
Kim, S. U. [1 ]
机构
[1] Yonsei Univ, Coll Med, Dept Internal Med, Inst Gastroenterol, Seoul, South Korea
关键词
D O I
10.1016/S1201-9712(11)60046-5
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:S11 / S12
页数:2
相关论文
共 50 条
  • [31] Risk factors and prognostic model for HBV-related subacute liver failure
    Xu, Juan
    Du, Fenjing
    Yang, Nan
    Hou, Jingtao
    Fan, Yan
    Liu, Xiaojing
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (07)
  • [32] Guideline change for antiviral therapy reduced the risk of HBV-related HCC development among cirrhotic patients in South Korea
    Kim, David
    Lee, Jae Seung
    Chun, Ho Soo
    Lee, Hye Won
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Han, Kwang-Hyub
    Lee, Yu Rim
    Tak, Won Young
    Kweon, Young Oh
    Ahn, Sang Hoon
    Kim, Seung Up
    JOURNAL OF HEPATOLOGY, 2020, 73 : S880 - S880
  • [33] HCC risk in patients with HBV-related cirrhosis receiving nucleos(t)ide analogues therapy: Is HCC prevented or delayed?
    Su, Tung-Hung
    Tseng, Tai-Chung
    Kao, Jia-Horng
    HEPATOLOGY, 2018, 67 (04) : 1634 - 1635
  • [34] Benefit of Antiviral Therapy for HBV-Related HCC with Undetectable HBV DNA Is Still Dubious
    Giri, Suprabhat
    Darak, Harish
    Kasturi, Sunil
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (10) : 4962 - 4964
  • [35] Benefit of Antiviral Therapy for HBV-Related HCC with Undetectable HBV DNA Is Still Dubious
    Suprabhat Giri
    Harish Darak
    Sunil Kasturi
    Digestive Diseases and Sciences, 2022, 67 : 4962 - 4964
  • [36] Limited diagnostic value of liver stiffness for clinically significant portal hypertension in HBV-related cirrhosis
    Mengmeng Zhang
    Xiaoxia Niu
    Di Zhao
    Ruping Qi
    Xuexin Qi
    Jinghui Dong
    Yuan Liu
    Xu Bai
    Qiang Yu
    Changchun Liu
    Jianming Cai
    Abdominal Radiology, 2022, 47 : 3712 - 3723
  • [37] Limited diagnostic value of liver stiffness for clinically significant portal hypertension in HBV-related cirrhosis
    Zhang, Mengmeng
    Niu, Xiaoxia
    Zhao, Di
    Qi, Ruping
    Qi, Xuexin
    Dong, Jinghui
    Liu, Yuan
    Bai, Xu
    Yu, Qiang
    Liu, Changchun
    Cai, Jianming
    ABDOMINAL RADIOLOGY, 2022, 47 (11) : 3712 - 3723
  • [38] Identification of Key Genes in the HBV-Related HCC Immune Microenvironment Using Integrated Bioinformatics Analysis
    Ding, Wei
    Zhang, Zheng
    Ye, Nianyuan
    Zhuang, Ling
    Yuan, Zhiping
    Xue, Wenbo
    Tan, Yulin
    Xu, Xuezhong
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [39] HBV whole-X and HBx play distinct roles in the HBV-related HCC progression
    Zhang, Yu
    Zhao, Yingren
    Liu, Hongli
    Yi, Ruitian
    Niu, Yinghua
    Cui, Meiling
    Liu, Jinfeng
    HEPATOLOGY, 2012, 56 : 617A - 617A
  • [40] Similar recurrence after curative treatment of HBV-related HCC regardless of HBV replication activity
    Kim, Mi Na
    Kim, Beom Kyung
    Cho, Heejin
    Goh, Myungji
    Yu, Su Jong
    Sinn, Dong Hyun
    Park, Soo Young
    Kim, Seung Up
    JOURNAL OF HEPATOLOGY, 2023, 78 : S513 - S514